The UK and India’s new £4.8bn free trade agreement (FTA) is expected to allow new opportunities for Indian medical device and pharmaceutical manufacturers.

Sarepta said it accepts the CHMP decision on Elevidys, while partner Roche said it will continue working with the EMA.

In today’s tech-driven landscape, it seems like every software solution in the clinical industry needs to have some AI ...

The clinical trial industry has long recognized the importance of standardization in driving efficiency and ensuring data quality. Efforts ...

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

GSK has secured approval in the European Union (EU) for Blenrep combinations to treat adults with relapsed or refractory multiple myeloma.

In 2025, Turbine took the first steps in opening its powerful cell simulation platform to the wider drug development ...

A federal district court in Delaware ruled that Viatris’ product, currently awaiting approval from the US Food and Drug Administration (FDA), does not infringe on Novo Nordisk’s patent for the ...

The EC has approved Janssen-Cilag International’s new indication for Darzalex Faspro (daratumumab) to treat adults with SMM.

Sanofi has signed an agreement to acquire Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities.

As clinical trial complexities grow, ICH E6 (R3) updates emphasize smarter monitoring, greater participant focus, and a stronger tech role.

Kling Bio has entered a partnership and licence option agreement with Sanofi to discover neutralising antibodies and epitopes.